Toll Free Phone: 1-866-892-2032
[email protected]
Servicing Healthcare Professionals and Companies
We Accept:
Never Overpay Again    |   5% First Order Discount   |   No Order Minimum   |   Free Replacement on Delays
Free Shipping After: $1000
OUR PRODUCTS
OUR BRANDS
Coming Soon
Tesamorelin 8mg Front
Tesamorelin 8mg Back
NOVERA COMPOUNDS

Tesamorelin (8mg)

This product is coming soon and is not yet available for purchase.

All products are 100% genuine and sourced from trusted manufacturers, with authenticity that can be verified for complete peace of mind.

Order exactly what you need with no minimum quantity required, whether it’s a single unit or a larger order.

Your order is guaranteed to arrive safely, with full shipment tracking and dedicated support to ensure a smooth delivery experience.

Your payments are protected with industry-standard encryption and trusted payment providers, ensuring every transaction is safe, private, and secure.

99% PURITY GUARANTEE

Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC). Full analytical reports are available in the Certificate of Analysis section.

Preparation & Handling Notice

The product is delivered in powdered (lyophilized) form and must be properly reconstituted prior to research use.

RESEARCH USE ONLY

This product is intended for research use only. It is not for human or veterinary use, not for diagnostic or therapeutic purposes, and should only be handled by qualified professionals.

Strength: 8 mg
CAS: 218949-48-5
Chemical Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
Molecular weight: 5136 g/mol
Peptide Sequence: Trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2
Synonyms: TH9507
Storage: Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
Shelf life: 24 months from the manufacturing date.

Tesamorelin (8 mg) is a synthetic peptide analog of human growth hormone–releasing hormone (GHRH), primarily used in research to study the biological processes involved in GHRH signaling. This peptide plays an essential role in endocrine studies, particularly for exploring the mechanisms of growth hormone release and its physiological effects within experimental models.

  • Cold chain shipping available for temperature-sensitive products.

  • Orders are processed within 1–2 business days.

  • Delivery timelines vary by destination and shipping method — view our Shipping Policy for region-specific estimates.

  • Tracking information will be provided once shipped.

  • No order minimum applies.

  • If your shipment is delayed, lost, or arrives damaged, you're covered under our Refund & Replacement Policy.

We accept Visa, Mastercard, and American Express. Apple Pay and Google Pay are available upon request via your account manager.

All transactions are processed through a secure, PCI DSS–compliant system to ensure your data is fully protected.

Why Choose NOVERA COMPOUNDS Peptides?

Novera Research delivers high-quality research peptides developed under strict manufacturing and quality-control standards. Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications.

  • High-purity, research-grade peptide synthesis
  • Analytical testing to verify quality and composition
  • Consistent batch-to-batch performance
  • Batch identification on every vial for traceability
  • Stored and shipped under controlled conditions
Why Choose Medica Depot Why Choose Medica Depot

Why Choose Medica Depot

Shop hundreds of medical products with no minimums and free shipping on large orders.

400+ products 400+ products
No order minimums No order minimums
Free shipping Free shipping
Loyalty rewards Loyalty rewards
Trusted since 2007 Trusted since 2007
Account manager Account manager
Verified LOT numbers Verified LOT numbers
Browse Products

INFORMATION

What is Tesamorelin (8 mg)?

Tesamorelin (8 mg) is a synthetic peptide analog of human growth hormone–releasing hormone (GHRH), primarily used in research to study the biological processes involved in GHRH signaling. This peptide plays an essential role in endocrine studies, particularly for exploring the mechanisms of growth hormone release and its physiological effects within experimental models.

Product Specifications

  • CAS Number: 218949-48-5
  • Peptide Sequence: Trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2
  • Category: Peptides
  • Subcategory: Muscle Growth & Performance Peptides
  • Molecular Weight: 5136 g/mol
  • Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
  • Synonyms: TH9507
  • Purity: ≥99%
  • Packaging Format: 8 mg
  • Storage Conditions: Store at -20°C, avoid light exposure
  • Designation: For Laboratory Research Use Only

Key Characteristics of Tesamorelin (8 mg)

  • A well-defined peptide sequence that ensures consistency in experimental setups.
  • Primarily used for studies on GHRH signaling and the evaluation of downstream biomarkers in endocrine models.
  • High purity (≥99%) to minimize variability and improve reliability in research workflows.
  • The 8 mg format is suitable for method development, repeated assays, and multi-stage research protocols.
  • Requires low-temperature, light-protected storage to support research applications.

How Tesamorelin (8 mg) Supports Research

Tesamorelin is a vital tool for investigating GHRH receptor signaling and its downstream biological responses in experimental systems. Researchers use this peptide to explore receptor engagement, signaling patterns, and the effects on metabolic functions in controlled environments. Tesamorelin’s design facilitates the investigation of metabolic signaling pathways and endocrine signaling dynamics in model systems.

Research Applications & Usage Information

Tesamorelin (8 mg) is commonly used in laboratory research for:

  • Endocrine signaling studies examining GHRH-related pathways and downstream marker shifts.
  • Profiling receptor interactions and comparing signaling responses across different peptide tools.
  • Protein signaling and gene-expression research, focusing on growth hormone-related markers.
  • Assay development and validation, ensuring repeatability and consistency in research.
  • Analytical verification, confirming peptide identity and comparability across experimental conditions.

Note: This material is intended for laboratory research only. Research methods and models may vary by institution and protocol.

Handling and Storage Recommendations

  • Store at 2–8°C (≤–20°C for long-term storage). Protect from light (keep the vial in its original packaging or use a light-blocking container).
  • Minimize freeze-thaw cycles to support research applications.
  • Keep the vial tightly sealed and use proper laboratory techniques to prevent contamination.
  • Follow your facility’s chemical hygiene plan, labeling rules, and disposal procedures.

Research Use Only Notice

This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.

References

  1. Tesamorelin. PubChem Compound Summary for CID 16137828. Bethesda, MD: National Center for Biotechnology Information; 2025. https://pubchem.ncbi.nlm.nih.gov/compound/Tesamorelin
  2. US Food and Drug Administration. Pharmacology Review(s). NDA/BLA 022505Orig1s000PharmR. Silver Spring, MD: US FDA; 2010. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022505Orig1s000PharmR.pdf
  3. US Food and Drug Administration. Tesamorelin acetate. GSRS/GINAS substance record; UNII LGW5H38VE3. Silver Spring, MD: US FDA. https://precision.fda.gov/ginas/app/ui/substances/0815de8e-8238-401d-a2f6-f88577ae1947
  4. Izdebski J, Pinski J, Horvath JE, Halmos G, Groot K, Schally AV. Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone. Proc Natl Acad Sci U S A. 1995;92(11):4872-4876. doi:10.1073/pnas.92.11.4872

What is Tesamorelin (8 mg)?

Tesamorelin (8 mg) is a synthetic peptide analog of human growth hormone–releasing hormone (GHRH), primarily used in research to study the biological processes involved in GHRH signaling. This peptide plays an essential role in endocrine studies, particularly for exploring the mechanisms of growth hormone release and its physiological effects within experimental models.

Product Specifications

  • CAS Number: 218949-48-5
  • Peptide Sequence: Trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2
  • Category: Peptides
  • Subcategory: Muscle Growth & Performance Peptides
  • Molecular Weight: 5136 g/mol
  • Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
  • Synonyms: TH9507
  • Purity: ≥99%
  • Packaging Format: 8 mg
  • Storage Conditions: Store at -20°C, avoid light exposure
  • Designation: For Laboratory Research Use Only

Key Characteristics of Tesamorelin (8 mg)

  • A well-defined peptide sequence that ensures consistency in experimental setups.
  • Primarily used for studies on GHRH signaling and the evaluation of downstream biomarkers in endocrine models.
  • High purity (≥99%) to minimize variability and improve reliability in research workflows.
  • The 8 mg format is suitable for method development, repeated assays, and multi-stage research protocols.
  • Requires low-temperature, light-protected storage to support research applications.

How Tesamorelin (8 mg) Supports Research

Tesamorelin is a vital tool for investigating GHRH receptor signaling and its downstream biological responses in experimental systems. Researchers use this peptide to explore receptor engagement, signaling patterns, and the effects on metabolic functions in controlled environments. Tesamorelin’s design facilitates the investigation of metabolic signaling pathways and endocrine signaling dynamics in model systems.

Research Applications & Usage Information

Tesamorelin (8 mg) is commonly used in laboratory research for:

  • Endocrine signaling studies examining GHRH-related pathways and downstream marker shifts.
  • Profiling receptor interactions and comparing signaling responses across different peptide tools.
  • Protein signaling and gene-expression research, focusing on growth hormone-related markers.
  • Assay development and validation, ensuring repeatability and consistency in research.
  • Analytical verification, confirming peptide identity and comparability across experimental conditions.

Note: This material is intended for laboratory research only. Research methods and models may vary by institution and protocol.

Handling and Storage Recommendations

  • Store at 2–8°C (≤–20°C for long-term storage). Protect from light (keep the vial in its original packaging or use a light-blocking container).
  • Minimize freeze-thaw cycles to support research applications.
  • Keep the vial tightly sealed and use proper laboratory techniques to prevent contamination.
  • Follow your facility’s chemical hygiene plan, labeling rules, and disposal procedures.

Research Use Only Notice

This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.

References

  1. Tesamorelin. PubChem Compound Summary for CID 16137828. Bethesda, MD: National Center for Biotechnology Information; 2025. https://pubchem.ncbi.nlm.nih.gov/compound/Tesamorelin
  2. US Food and Drug Administration. Pharmacology Review(s). NDA/BLA 022505Orig1s000PharmR. Silver Spring, MD: US FDA; 2010. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022505Orig1s000PharmR.pdf
  3. US Food and Drug Administration. Tesamorelin acetate. GSRS/GINAS substance record; UNII LGW5H38VE3. Silver Spring, MD: US FDA. https://precision.fda.gov/ginas/app/ui/substances/0815de8e-8238-401d-a2f6-f88577ae1947
  4. Izdebski J, Pinski J, Horvath JE, Halmos G, Groot K, Schally AV. Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone. Proc Natl Acad Sci U S A. 1995;92(11):4872-4876. doi:10.1073/pnas.92.11.4872
CART (0)

No products in the cart.